TherapeuticsMD, Inc. financial data

Symbol
TXMD on Nasdaq
Location
951 Yamato Road, Suite 220, Boca Raton, FL
State of incorporation
Nevada
Fiscal year end
December 31
Former names
AMHN, Inc. (to 9/14/2011), CROFF ENTERPRISES INC (to 9/4/2009), CROFF OIL CO (to 4/1/1997)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 134 % +166%
Quick Ratio 3.44 % -67.9%
Debt-to-equity 71.8 %
Return On Equity -21.4 % -106%
Return On Assets -19.9 % -122%
Operating Margin 59.9 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.5M shares +9.05%
Common Stock, Shares, Outstanding 11.5M shares +9.05%
Entity Public Float 34.4M USD -60.6%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +12.8%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.4M USD +246%
Research and Development Expense 5.51M USD -31.6%
Selling and Marketing Expense 83.7M USD -36.2%
General and Administrative Expense 56.7M USD -29.8%
Operating Income (Loss) -2.44M USD +1.29%
Nonoperating Income (Expense) 1.39M USD +2297%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.05M USD +56.5%
Income Tax Expense (Benefit) -260K USD
Net Income (Loss) Attributable to Parent -6.09M USD -114%
Earnings Per Share, Basic -0.09 USD/shares +62.5%
Earnings Per Share, Diluted -0.09 USD/shares +62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 32.2M USD -14%
Inventory, Net 6.7M USD -8.98%
Assets, Current 11.8M USD -39.7%
Property, Plant and Equipment, Net 19K USD -96.6%
Operating Lease, Right-of-Use Asset 6.5M USD -10.1%
Intangible Assets, Net (Excluding Goodwill) 4.52M USD -33.1%
Other Assets, Noncurrent 58K USD -77.2%
Assets 40.1M USD -25.3%
Accounts Payable, Current 143K USD -90.5%
Employee-related Liabilities, Current 526K USD -81.5%
Liabilities, Current 5.82M USD -59.5%
Operating Lease, Liability, Noncurrent 6.53M USD -11.4%
Other Liabilities, Noncurrent 637K USD -46.4%
Liabilities 12.5M USD -44.6%
Retained Earnings (Accumulated Deficit) -951M USD -0.64%
Stockholders' Equity Attributable to Parent 27.7M USD -11.3%
Liabilities and Equity 40.1M USD -25.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.7M USD +51.3%
Net Cash Provided by (Used in) Financing Activities -5M USD -105%
Net Cash Provided by (Used in) Investing Activities -212K USD +51.6%
Common Stock, Shares Authorized 32M shares 0%
Common Stock, Shares, Issued 11.5M shares +9.05%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.23M USD -61.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.36M USD -40.1%
Deferred Tax Assets, Valuation Allowance 200M USD -23.4%
Deferred Tax Assets, Gross 200M USD -23.4%
Operating Lease, Liability 8.01M USD -8.61%
Depreciation 100K USD -83.3%
Payments to Acquire Property, Plant, and Equipment 42K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD -109%
Lessee, Operating Lease, Liability, to be Paid 10.4M USD -12.2%
Property, Plant and Equipment, Gross 2.52M USD -0.04%
Operating Lease, Liability, Current 1.59M USD +9.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD +2.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48M USD +2.36%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.42M USD -22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.55M USD +2.51%
Deferred Tax Assets, Operating Loss Carryforwards 158M USD -10.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.59M USD +2.52%
Additional Paid in Capital 979M USD
Depreciation, Depletion and Amortization 180K USD +40.6%
Share-based Payment Arrangement, Expense 1.3M USD -88.8%
Interest Expense 300K USD +50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%